Healthcare


 4Front Ventures Corp.'s (CSE:FFNT) shares have surged by 33%, making the price attractive, though growth remains limited.

4Front Ventures Corp.'s (CSE:FFNT) shares have surged by 33%, making the price attractive, though growth remains limited.

February 10, 2025 05:32 AM AEDT| By Team Kalkine Media

4Front Ventures Corp. (CSE:FFNT) and Its Market Journey

 Is Medexus Facing Hidden Challenges Despite Revenue Growth?

Is Medexus Facing Hidden Challenges Despite Revenue Growth?

February 09, 2025 09:32 AM AEDT| By Team Kalkine Media

Is Medexus Facing Hidden Challenges Despite Revenue Growth?

 Aurora Cannabis Reports Financial Performance In The Healthcare Sector

Aurora Cannabis Reports Financial Performance In The Healthcare Sector

February 08, 2025 08:32 AM AEDT| By Team Kalkine Media

Aurora Cannabis Reports Financial Performance In The Healthcare Sector

 Is Vext Science Redefining Canada's Pharma Sector?

Is Vext Science Redefining Canada's Pharma Sector?

February 08, 2025 03:37 AM AEDT| By Team Kalkine Media

Highlights,Notable contrast between revenue trends and overall industry performance.,Observations center on the price-to-sales ratio alignment with sector norms.,Operational developments are reflected in recent financial dynamics.,Within Canada's pha...

 Fennec Pharmaceuticals Inc. (TSX: FRX) Announces PEDMARQSI Launch in Germany for Ototoxicity Prevention

Fennec Pharmaceuticals Inc. (TSX: FRX) Announces PEDMARQSI Launch in Germany for Ototoxicity Prevention

February 07, 2025 11:36 PM AEDT| By Team Kalkine Media

Highlights,Norgine Pharmaceuticals launches PEDMARQSI in Germany to prevent cisplatin-induced hearing loss.,Fennec received a $43M upfront payment under licensing deal with Norgine.,PEDMARQSI is the first approved therapy for cisplatin-induced ototox...

 Can Avant Brands Address Its Short-Term Financial Shortfall?

Can Avant Brands Address Its Short-Term Financial Shortfall?

February 07, 2025 12:32 PM AEDT| By Team Kalkine Media

Can Avant Brands Address Its Short-Term Financial Shortfall?

 What’s Causing Oncolytics Biotech’s Struggles In The Market?

What’s Causing Oncolytics Biotech’s Struggles In The Market?

February 06, 2025 01:30 AM AEDT| By Team Kalkine Media

Highlights:,Oncolytics Biotech operates in the biotechnology sector, focusing on cancer treatments.,The company’s financial data reflects high liquidity and a modest debt level.,The firm has reported a loss per share for its most recent quarter.,Onco...

 Could High Debt Pressure Sienna’s Financial Stability In The Future?

Could High Debt Pressure Sienna’s Financial Stability In The Future?

January 31, 2025 04:00 PM AEDT| By Team Kalkine Media

Highlights,:,Extendicare is the largest private-sector operator of long-term care homes in Canada.,The company focuses on providing publicly funded home health care services.,Extendicare's stock has shown consistent fluctuations in recent months.,Ext...

 What’s Behind Sienna Senior Living’s Volatile Market Performance

What’s Behind Sienna Senior Living’s Volatile Market Performance

January 31, 2025 04:00 PM AEDT| By Team Kalkine Media

Highlights:,Sienna Senior Living focuses on senior living and long-term care services.,The company operates in Canada, offering diverse living and care solutions.,Sienna's stock has experienced fluctuations, reflecting its performance in the sector.,...

 Will Profound Medical Overcome Financial Setbacks In Time?

Will Profound Medical Overcome Financial Setbacks In Time?

January 31, 2025 01:52 AM AEDT| By Team Kalkine Media

Highlights:,Profound Medical has expanded its losses in recent years.,The company is expected to break even within two years, according to industry experts.,The business has managed its capital with a low debt-to-equity ratio.,Profound Medical,(TSX:P...

 Why Did Jamieson Wellness Decide to Renew Its Share Repurchase Program?

Why Did Jamieson Wellness Decide to Renew Its Share Repurchase Program?

January 30, 2025 11:50 PM AEDT| By Team Kalkine Media

Highlights:,Jamieson Wellness Inc. has received approval from the Toronto Stock Exchange (TSX) for a renewed normal course issuer bid (NCIB).,The Company can purchase up to approximately 10% of its public float in common shares for cancellation.,The...

 Is WELL Health’s Stock Struggling To Meet Growth Goals?

Is WELL Health’s Stock Struggling To Meet Growth Goals?

January 30, 2025 12:59 AM AEDT| By Team Kalkine Media

Highlights:,WELL Health Technologies Corp. experiences slight share price increase,Strong liquidity ratios indicate sound financial position,Market cap reflects company’s standing within the healthcare sector,WELL Health Technologies Corp.,(TSX:WELL)...

 HLS Therapeutics A Challenging Quarter for the Pharmaceutical Company

HLS Therapeutics A Challenging Quarter for the Pharmaceutical Company

January 29, 2025 04:00 PM AEDT| By Team Kalkine Media

Highlights:,HLS Therapeutics shares decline with reduced trading volume,Company reports negative earnings and challenges with profitability,Financial ratios indicate significant debt and liquidity concerns,HLS Therapeutics,(TSX:HLS),operates within t...

 Treatment.com AI Inc. (CSE: TRUE) Announces Binding Letter of Intent to Acquire Alea Health Holdings

Treatment.com AI Inc. (CSE: TRUE) Announces Binding Letter of Intent to Acquire Alea Health Holdings

January 28, 2025 10:48 PM AEDT| By Team Kalkine Media

Highlights,Treatment.com AI to acquire Alea Health, enhancing AI-driven mental health care capabilities.,Alea Health’s AI platform optimizes patient engagement and streamlines administrative processes.,Acquisition strengthens Treatment’s position in...

 MindBio Therapeutics (CSE: MBIO) Reports Independent Safety Audit Success in Landmark Phase 2B Clinical Trials for Depression and Cancer-Related Distress

MindBio Therapeutics (CSE: MBIO) Reports Independent Safety Audit Success in Landmark Phase 2B Clinical Trials for Depression and Cancer-Related Distress

January 28, 2025 10:45 PM AEDT| By Team Kalkine Media

Highlights,MindBio Therapeutics reports no serious adverse events in its Phase 2B trials for depression and cancer-related distress.,The independent safety audit clears both trials to continue toward completion in late 2025.,MB22001, a non-hallucinog...

 Is Knight Therapeutics Facing Challenges In Market Performance?

Is Knight Therapeutics Facing Challenges In Market Performance?

January 28, 2025 04:00 PM AEDT| By Team Kalkine Media

Highlights:,Knight Therapeutics sees a slight dip in stock price.,The company has a market capitalization of C$576.90 million.,A decrease in trading volume observed, with a notable drop in shares traded.,Knight Therapeutics Inc.,(TSX:GUD),, a leading...

 Will Oncolytics Biotech's Current Spending Stifle Its Progress?

Will Oncolytics Biotech's Current Spending Stifle Its Progress?

January 28, 2025 04:00 PM AEDT| By Team Kalkine Media

Highlights:,Oncolytics Biotech faces a relatively short cash runway based on current burn rate.,Cash burn reduced by nearly 10% over the last year, signaling some progress.,Raising additional funds could lead to significant shareholder dilution due t...

 Could NorthWest Healthcare's Earnings Fall Short in the Coming Year?

Could NorthWest Healthcare's Earnings Fall Short in the Coming Year?

January 27, 2025 10:17 PM AEDT| By Team Kalkine Media

Highlights:,National Bank Financial reduces FY2025 earnings per share estimate for NorthWest Healthcare Properties Real Estate Investment Trust.,New forecast for FY2025 EPS set at $0.44, a slight decrease from the previous estimate.,National Bank Fin...

 Has Medexus Pharmaceuticals Reached Its Peak Amid Market Trends?

Has Medexus Pharmaceuticals Reached Its Peak Amid Market Trends?

January 27, 2025 04:00 PM AEDT| By Team Kalkine Media

Highlights,Medexus Pharmaceuticals shows fluctuating stock performance over the past year.,The company has experienced significant price movement, reflecting market volatility.,Medexus carries a high price-to-earnings ratio and relatively high market...

 How Will Voyageur Pharmaceuticals' New Capital Structure Impact Its Growth?

How Will Voyageur Pharmaceuticals' New Capital Structure Impact Its Growth?

January 25, 2025 05:57 AM AEDT| By Team Kalkine Media

Highlights,Voyageur Pharmaceuticals,(TSXV:VM),raises over $680,000 through warrant exercises.,The exercises involve more than 5.7 million share purchase warrants.,The company's capital structure is streamlined with the issuance of new common shares.,...

Canadian AI All-Stars: Unveiling the Top Stocks for 2025

Send OTP Resend OTP in 30s

Recent Articles






Investing Tips

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.